Simultaneous Estimation and Validation of Four Antiepileptic Drugs from Bulk and Formulations Using Reverse Phase HPLC
DOI:
https://doi.org/10.1590/s2175-97902023e20692Keywords:
Antiepileptic, HPLC, Simultaneous estimation, ValidationAbstract
Epilepsy is a disorder of the central nervous system, in which the nerve cell activity in the brain is disturbed causing seizures. The objective was to develop an RP-HPLC method for consistent simultaneous quantitation of four antiepileptic drugs Levetiracetam (LVT), Lamotrigine (LTG), Phenobarbital (PBT) and Phenytoin (PTY). An isocratic method was developed on C18 column in JASCO HPLC using 5 mM potassium phosphate buffer (pH 6) and acetonitrile as the mobile phase at a flow rate of 1ml/min and detected at 230 nm using UV detector. The mean retention time for LVT, LTG, PBT and PTY were found as 2.55, 3.55, 4.65 and 5.99 minutes respectively. The method was validated as per ICH guidelines and was found to be acceptable. The %RSD value was <2.0 % thus stating the developed method was precise for the drugs in the given range. The accuracy values were within 85-115% of the recovery range. The specificity of the method was evaluated by an assay of marketed formulation, and it showed a percent content between 90-110% w/w for all the four drugs. The proposed analytical method was simple, accurate and robust and was precisely able to resolve the four major antiepileptic drugs. Hence, the current method can be applied successfully for routine examination of these drugs.
Downloads
References
Aneja S, Sharma S. Newer Anti-epileptic Drugs. Indian Pediatrics. 2013;50:1033-40.
Dooley M, Plosker GL. Levetiracetam. Drugs. 2000;60(4): 871-893.
Emami J, Ghassami N, Ahmadi F. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations. J Pharmaceut Biomed. 2006;40(4)999-05
FDA Approved Drugs: Levetiracetam Tablets https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021035s100,021505s040lbl.pdf
» https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021035s100,021505s040lbl.pdf
Ferreira A, Rodrigues M, Oliveira P, Francisco J, Fortuna A, Rosado L, et al. Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine. J Chromatogr B. 2014;971:20-29.
García ZL, Requejo VH, Huertas-González N. Double therapy in partial epilepsy: lamotrigine and levetiracetam, 2016. https://www.researchgate.net/publication/307638759_Double_therapy_in_partial_epilepsy_lamotrigine_and_levetiracetam
Ghatol S, Vithlani V, Gurule S, Khuroo A, Monif T, Partani P. Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma: application to a pharmacokinetic study. J Pharm Anal. 2013;3(2):75-83.
Guidelines ICH, Harmonised Tripartite. Guideline validation of analytical procedures: text and methodology Q2(R1) current Step 4 version Parent Guideline dated 27 October 1994.
Hashem H, El-Sayed HM. Quality by design approach for development and validation of a RP-HPLC method for simultaneous determination of co-administered levetiracetam and pyridoxine HCl in prepared tablets. Microchem J. 2018;143:55-63.
Joshi P, Bhoir S, Jadhav R, Vishwanath K. Stability-Indicating LC method for analysis of lamotrigine and use of the method to study degradation kinetics. J Adv Pharm Technol Res. 2011;2(4):142-149.
Kang J, Park YS, Kim SH, Kim SH, Jun MY. Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring. Korean J Physiol Pharmacol. 2011;15(2):67-81.
Leach MJ, Marden CM, Miller A. A Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: Neurochemical studies on the mechanism of action. Epilepsia. 1986;27(5):490-497.
Methaneethorn J, Leelakanok N. Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis. Eur J Clin Pharmacol. 2021;77(3):291-309.
Praveen AN, Panchaksharimath P, Nagaraj KA. Comparative study to evaluate the efficacy and safety of levetiracetam as an add-on to carbamazepine and phenytoin in focal seizures at a tertiary care hospital. Biomed Pharmacol J. 2020;13(1):383-390.
PubChem Identifier: CID 3878 URL: https://pubchem.ncbi. nlm.nih.gov/compound/3878
» https://pubchem.ncbi. nlm.nih.gov/compound/3878
PubChem Identifier: 5284583 URL: https://pubchem.ncbi. nlm.nih.gov/compound/5284583
» https://pubchem.ncbi. nlm.nih.gov/compound/5284583
PubChem Identifier 4763 URL: https://pubchem.ncbi.nlm. nih.gov/compound/4763
» https://pubchem.ncbi.nlm. nih.gov/compound/4763
PubChem Identifier 1775 URL: https://pubchem.ncbi.nlm. nih.gov/compound/1775
» https://pubchem.ncbi.nlm. nih.gov/compound/1775
Rama VR, Kherb GJ, Dubalb KL, Pandyab GP, Joshib HS. Development and validation of a stability indicating HPLC assay method for determination of Lamotrigine in tablet formulation. Pelagia Res Library Chem Sinica. 2011;2(2):58-65.
Reddy S. Clinical Pharmacology and Therapeutics of Antiepileptic Drugs . Int J Pharm Sci Nanotechnol. 2020;13(6):5165-5180.
Sarhan E, Walker M, Selai C. Evidence for efficacy of combination of antiepileptic drugs in treatment of epilepsy. J Neurol Res. 2015; 5(6):267-276.
Sommerfeld-Klatta K, Zielińska-Psuja B, Karaźniewcz-Łada M, Główka FK. New methods used in pharmacokinetics and therapeutic monitoring of the first and newer generations of antiepileptic drugs (AEDs). Molecules. 2020;25(21):5083
Tyagi M, Kannan S, Manickam A, Chander J. A novel HPLC estimation technique for the antiepileptic drug levetiracetam in tablet and human urine samples. World J Pharm Pharm Sci. 2015;4(6):1093-1099.
Varaprasad A, Sriram N, Godwin Isaac Blessing A, Jawahar M, Thangamuthu S. Method development and validation of phenytoin sodium in bulk and its pharmaceutical dosage form by RP-HPLC method. Int J Bio Pharm Res 2012;3:126-129.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
